ID | 1105 |
Name of the vaccine | mORC-Vax |
Microbe | Bacteria |
Disease name | Cholera |
Name of bacteria | Vibrio cholerae |
Type of vaccine | Inactivated |
Nucleic acid content | DNA |
Age | 2 years and older |
Description of the vaccine | Bivalent, killed whole-cell (O1 and O139 serogroups). Licensed only in Vietnam. |
Name of the manufacturer | Vabiotech, Hanoi |
Name of the manufacturing country | Vietnam |
Year of manufacture | 2009 |
Clinical Phase status | Approved |
Bacterial strain | Gram-negative bacteria. |
Efficacy | Seroconversion rates of vibriocidal antibodies of 91% among adults in Vietnam, 53% among adults in Kolkata and 80% among children aged greater than 1 year. |
Vaccine formulation | NA |
Dosage | Two doses, gap of 14 days. |
Mechanism of action | NA |
Route of administration | Oral |
Indications | NA |
Export | Not for international use |
Approval | Not WHO prequalified. |
Adjuvant | NA |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | 31879125 |
Clinical trial number | NA |
Reference | https://www.who.int/bulletin/volumes/92/12/14-139949.pdf?ua=1 |
Other name | NA |
Additional Links | NA
|